LifeMD Inc reports results for the quarter ended March 31 - Earnings Summary

• LifeMD Inc LFMD.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -19 cents. The mean expectation of seven analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -11 cents tozero cents per share.

• Revenue rose 48.8% to $65.70 million from a year ago; analysts expected $62.55 million.

• LifeMD Inc's reported EPS for the quarter was 1 cent​.

• The company reported quarterly net income of $608 thousand.

• LifeMD Inc shares had risen by 38.6% this quarter and gained 52.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 11.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for LifeMD Inc is $12.00

This summary was machine generated from LSEG data May 6 at 11:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)